Lexicon Pharma (LXRX) Reports Q4 EPS of $0.76
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.18 +1.40%
Revenue Growth %: -86.1%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -86.1%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of $0.76, versus ($0.03) reported last year. Revenue for the quarter came in at $127.3 million, versus $21.5 million reported last year.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Qualcomm investor day to detail data center plans Wednesday
- Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
